Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice
Conclusion:
Together, our data presented a novel role for VDRA and ACEI in reducing factors associated with CHD that may lead to the discovery of new therapeutic venues.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Suarez-Martinez, E., Husain, K., Ferder, L. Tags: Original Research Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Enalapril | Genetics | Heart | Heart Disease | Study | Vitamin D Deficiency | Vitamins